Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
about
NKT cell subsets as key participants in liver physiology and pathologyHepatitis B virus reactivation with a rituximab-containing regimenHepatitis B virus reactivation with rituximab-containing regimenVirus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and CSpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisPraziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in miceHepitopes: A live interactive database of HLA class I epitopes in hepatitis B virusPartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.Prevention of hepatitis B virus reactivation under rituximab therapy.Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccinationContribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic InfectionThe woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infectionComputational modeling of interventions and protective thresholds to prevent disease transmission in deploying populationsDynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatmentExpression of hepatitis B virus x protein in hepatocytes suppresses CD8 T cell activity.Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapyDeficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.HLA-DPB1 Variant Effect on Hepatitis B Virus Clearance and Liver Cirrhosis Development Among Southwest Chinese PopulationPegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis BCD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients.Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infectionBiology and significance of T-cell apoptosis in the liver.Control or persistence of hepatitis B virus: the critical role of initial host-virus interactions.A mouse model for studying the clearance of hepatitis B virus in vivo using a luciferase reporter.Immune response and tolerance during chronic hepatitis B virus infection.Viral determinants and host immune responses in the pathogenesis of HBV infection.Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infectionCombined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.Molecular viral oncology of hepatocellular carcinoma.Kinetics of phytohemaglutinin-induced IFN-gamma and TNF-alpha expression in peripheral blood mononuclear cells from patients with chronic hepatitis B after liver transplantationT regulatory cells: aid or hindrance in the clearance of disease?The role of cells refractory to productive infection in acute hepatitis B viral dynamics.The level of viral antigen presented by hepatocytes influences CD8 T-cell function.
P2860
Q26766141-E1816CEA-D1A8-451E-BB63-E3A8DAFAA838Q26785963-5FE5A301-A28C-4EF4-B909-28686A4CC9DEQ26830484-E0BB3A6A-D8FD-458D-B1A1-485F8C46CDA4Q27472920-4C8744CE-9900-495A-95B4-35CB96C08DF7Q28074434-30E67F2A-227A-499B-9822-17792BBEBF07Q28477371-77121644-AD37-48A2-AEF0-6E5BB8D2E23CQ28588907-4F3ED578-C1FA-419E-BFC4-9396671135AEQ28742762-8EE02FE2-48EF-4413-A6A8-B4A6361DD7F1Q30854409-5AE788DC-50A0-4370-BB45-DFD6943924CBQ33211869-22A63C57-6376-4080-9A77-673693EB262EQ33390799-503E9E24-0BC6-4C78-9A48-13D957C71D99Q33525552-E7AF7B89-30F0-4222-B6BC-C36E7672A6FDQ33680736-8F20300B-AAF0-4613-99D7-C46C83AFA48CQ33734554-DD186A1D-D1EF-470B-B8E6-D8D195B2F269Q33757923-349DCFD2-C413-4817-B08D-20AEC3280FB2Q33787525-DF832454-278D-4120-B59E-7D7BF118D3A0Q33804835-3236B3B8-BD8F-47B7-AD48-CD2914373C00Q33867462-3BF5E46D-FE25-415A-9B8D-ABE514B7E8D3Q34127443-C6FCCFC0-89B5-43BB-BDE6-75F1DD43D9DBQ34151071-8D99BD00-5C5C-4A55-839F-0B103D079508Q34330734-5AA99AD5-E015-487E-B41D-D8445B15C2A2Q34348786-77870B7F-9F2F-4242-BB17-B78D7E441F2EQ34450653-FCE127F5-9A9C-4A04-8D55-57BF629198C4Q34462354-47D143DA-62E0-4A6F-A8D4-56D584966A66Q34469926-ADA58AA1-E8B2-4C04-97B0-54CE0240B27CQ34545726-69C43993-3D68-42FA-B933-F5D444F38FB6Q34546442-8BD5B77E-8692-4FF8-BB00-7FA818F916FFQ34546460-2E1E0A30-3448-478D-A806-E43B4E9B5D13Q34663633-79EF0A24-AD97-4F2B-A6BF-30BFC9E6669BQ34700332-B038E01C-20F7-4F72-999A-ED328F323912Q34737124-E6698B27-B077-4EC2-A614-56FFED100615Q34778476-308189D5-E7AC-4EDE-921B-F1D05AC4BCABQ34988967-D2954CC6-4EC7-4B3B-939E-097AA0008A1FQ35078104-CA15AEDE-770E-4F0A-A760-5656F7E92C0DQ35092599-A1756F6E-9797-468C-8CF2-75EDC4AC8C7CQ35196596-F88B2F57-BCEA-4C9C-94D8-1A0C65109DB5Q35435517-EC3653F0-7EBE-4DC6-8D59-6A6008507F62Q35459820-C7E20DD0-E3E6-4443-AD7F-446E355DCDC6Q35691056-F4DBF152-F00B-4D7C-AAFD-ACEDABC36CE2Q35784981-27686C54-5558-4093-AB92-B4A6B32515A1
P2860
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
description
im November 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2000
@uk
name
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@en
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@nl
type
label
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@en
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@nl
prefLabel
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@en
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@nl
P2093
P356
P1433
P1476
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
@en
P2093
A Bertoletti
G J Webster
G M Dusheiko
R Williams
S A Whalley
P304
P356
10.1053/JHEP.2000.19324
P407
P50
P577
2000-11-01T00:00:00Z